- $1.46bn
- $1.93bn
- $3.11bn
- 46
- 68
- 59
- 59
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 5.19 | ||
| PEG Ratio (f) | 0.23 | ||
| EPS Growth (f) | 28.4% | ||
| Dividend Yield (f) | 4.53% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 2.56 | ||
| Price to Tang. Book | 2.89 | ||
| Price to Free Cashflow | 33.4 | ||
| Price to Sales | 0.43 | ||
| EV to EBITDA | 8.52 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 5.76% | ||
| Return on Equity | 33.92% | ||
| Operating Margin | 5.83% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | n/a | n/a | 1,166.56 | 2,421.99 | 3,111.49 | 3,958.11 | 4,520.92 | 63.32% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | +213.88 | -25 | +88.52 | +28.4 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
PACS Group, Inc. is a holding company investing in post-acute healthcare facilities, professionals, and ancillary services. The Company is focused on delivering skilled nursing care through a portfolio of independently operated facilities. It also provides its independently operated facilities with a comprehensive suite of technology, support, and back-office services. The post-acute care ecosystem serves individuals who need additional help recuperating from acute conditions, illnesses, or serious medical procedures after they have been discharged from the hospital. This ecosystem ranges from higher acuity, higher-cost settings, such as long-term acute care hospitals and inpatient rehabilitation facilities, to lower acuity, lower-cost settings, such as assisted living facilities, and home health. The Company’s independent subsidiaries operate about 314 post-acute care and senior living facilities across 17 states, serving over 30,000 patients daily.
Directors
- Last Annual
- December 31st, 2023
- Last Interim
- June 30th, 2024
- Incorporated
- March 24th, 2023
- Public Since
- April 11th, 2024
- No. of Employees
- 32,433
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
New York Stock Exchange- Shares in Issue
- 152,399,733
- Address
- 262 N University Ave., FARMINGTON, 84025
- Web
- https://pacs.com/
- Phone
- +1 8014479829
- Auditors
- Ernst & Young LLP
Upcoming Events for PACS
Similar to PACS
Agilon Health
New York Stock Exchange
AMERICAN WELL
New York Stock Exchange
AMN Healthcare Services
New York Stock Exchange
Ardent Health Partners
New York Stock Exchange
Auna SA
New York Stock Exchange
FAQ
As of Today at 22:32 UTC, shares in PACS are trading at $9.60. This share price information is delayed by 15 minutes.
Shares in PACS last closed at $9.60 and the price had moved by -60.43% over the past 365 days. In terms of relative price strength the PACS share price has underperformed the S&P500 Index by -63.47% over the past year.
The overall consensus recommendation for PACS is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out morePACS does not currently pay a dividend.
PACS does not currently pay a dividend.
PACS does not currently pay a dividend.
To buy shares in PACS you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $9.60, shares in PACS had a market capitalisation of $1.46bn.
Here are the trading details for PACS:
- Country of listing: United States
- Exchange: NYQ
- Ticker Symbol: PACS
Based on an overall assessment of its quality, value and momentum PACS is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in PACS is $35.60. That is 270.83% above the last closing price of $9.60.
Analysts covering PACS currently have a consensus Earnings Per Share (EPS) forecast of $1.44 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like PACS. Over the past six months, its share price has underperformed the S&P500 Index by -75.96%.
As of the last closing price of $9.60, shares in PACS were trading -59.56% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The PACS PE ratio based on its reported earnings over the past 12 months is 5.19. The shares last closed at $9.60.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on PACS' directors